Comparative Efficacy of Liver Fibrosis and Steatosis Assessment With Fibroscan and iLivTouch (OGIG-01-22-LF)
Comparative Efficacy of Liver Fibrosis and Steatosis Assessment With Fibroscan and iLivTouch in Patients With Chronic Liver Diseases
Sponsor: Federal State Budgetary Scientific Institution Federal Research Centre of Nutrition, Biotechnology
Listed as NCT05224037, this NA trial focuses on Chronic Liver Disease and Liver Fibrosis and remains completed. Sponsored by Federal State Budgetary Scientific Institution Federal Research Centre of Nutrition, Biotechnology, it has been updated 6 times since 2022, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
6 versions recorded-
Sep 2025 — Present [monthly]
Completed NA
-
Sep 2024 — Sep 2025 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
May 2023 — Jul 2024 [monthly]
Completed NA
Status: Recruiting → Completed
-
Sep 2022 — May 2023 [monthly]
Recruiting NA
▶ Show 1 earlier version
-
Mar 2022 — Sep 2022 [monthly]
Recruiting NA
First recorded
Jan 2022
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Federal State Budgetary Scientific Institution Federal Research Centre of Nutrition, Biotechnology
For direct contact, visit the study record on ClinicalTrials.gov .